Product image of Norditropin Simplexx (Somatropin) supplied by GNH India

Norditropin Simplexx

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Simplexx (Somatropin)

Somatropin, the active ingredient in Norditropin Simplexx, is a human growth hormone presented as an injection solution for subcutaneous administration. It is used to treat growth hormone deficiency and associated growth disorders in both pediatric and adult patients, supporting normal growth and metabolic function.

GNH India supplies Norditropin Simplexx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides cold‑chain logistics to ensure product integrity during global distribution.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Simplexx (somatropin) is used in growth hormone therapy to address conditions characterized by deficient endogenous growth hormone.

  • Growth hormone deficiency: Improves linear growth in children and restores normal metabolic function in adults.
  • Turner syndrome: Increases height velocity and supports development in affected females.
  • Chronic renal insufficiency: Enhances growth parameters in pediatric patients with renal disease.
  • Prader‑Willi syndrome: Promotes growth and improves body composition.
  • Short stature due to idiopathic GH deficiency: Facilitates catch‑up growth in children with unexplained short stature.

How It Works

  • Somatropin binds to specific growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators, which together promote proliferation of chondrocytes in the growth plate, protein synthesis, and lipolysis, resulting in increased linear growth and metabolic effects. Additionally, IGF‑1 acts in an endocrine and autocrine manner to further support tissue growth and bone mineralization.

Side Effects

Somatropin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Injection site pain: Discomfort or redness at the injection site.
  • Headache: Mild to moderate headache.
  • Edema: Mild peripheral fluid retention.
  • Nausea: Occasional feeling of nausea.

Serious or Rare Side Effects

  • Intracranial hypertension: Headache, visual changes, and papilledema.
  • Slipped capital femoral epiphysis: Hip pain and limited motion.
  • Acute pancreatitis: Severe abdominal pain with vomiting.
  • Allergic reactions: Rash, urticaria, or anaphylaxis.

Precautions & Warnings

When prescribing somatropin, clinicians should consider several precautionary measures to ensure safe use.

  • Monitor IGF‑1 levels: Adjust dose based on serial IGF‑1 measurements.
  • Screen for malignancy: Avoid use in patients with active cancer or known tumor recurrence.
  • Assess glucose tolerance: Watch for hyperglycemia, especially in diabetic patients.
  • Evaluate intracranial pressure: Be vigilant for signs of increased intracranial pressure.
  • Pediatric growth monitoring: Regularly assess growth velocity and bone age.
  • Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other agents, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Glucocorticoids: May antagonize growth‑promoting effects.
  • Antidiabetic drugs: Increased risk of hyperglycemia may require dose adjustment.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: Adjust thyroid dosing as GH can affect metabolism.
  • Estrogen therapy: May alter IGF‑1 response.
  • CYP450 inducers: Potentially affect metabolism of concomitant medications.

Frequently Asked Questions

Norditropin Simplexx contains somatropin, a recombinant human growth hormone. It is prescribed to treat growth hormone deficiency and related growth disorders such as Turner syndrome, chronic renal insufficiency, Prader‑Willi syndrome, and idiopathic short stature, helping patients achieve normal growth and metabolic balance.

Somatropin binds to growth hormone receptors on cell surfaces, triggering the JAK2‑STAT5 pathway. This leads to increased production of insulin‑like growth factor‑1 (IGF‑1) in the liver and other tissues, which stimulates bone growth, protein synthesis, and lipolysis, thereby promoting linear growth and metabolic effects.

The dose of Norditropin Simplexx is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, weight, clinical condition, and IGF‑1 response, and provides specific administration instructions.

Safety of somatropin in pregnancy or while breastfeeding has not been established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and decisions are made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Norditropin Simplexx is a recombinant somatropin formulation delivered as a ready‑to‑use injection solution. Compared with lyophilized powders that require reconstitution, it offers convenience and reduced preparation time, while providing comparable efficacy and safety profiles to other approved human growth hormone brands.

Store the product at 2‑8 °C (refrigerated), protected from light. Do not freeze or shake the vial. Keep it in the original packaging until use to maintain stability and potency.

Norditropin Simplexx is administered by subcutaneous injection, typically into the thigh, abdomen, or upper arm. The prescriber provides detailed instructions on injection technique, rotation of sites, and timing relative to meals or other medications.

Serious risks include intracranial hypertension, slipped capital femoral epiphysis, acute pancreatitis, severe allergic reactions (including anaphylaxis), and potential tumor recurrence in patients with a history of malignancy. Prompt medical evaluation is required if any of these symptoms appear.

Norditropin Simplexx should not be used in patients with active malignancy, known hypersensitivity to somatropin or any excipients, uncontrolled diabetes, or those with severe intracranial hypertension. Contra‑indications are determined by the prescribing clinician based on individual medical history.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT